I’m pleased to share with you two successful live cases from TCT 2017, held in Denver last week.
TCT is one of the biggest events in cardiology and this year, we had a strong presence there. During the live cases, both Occlutech AFR and Occlutech PLD had great attention of audience where the room was full.
Live Case 1; Occlutech AFR The case was performed by Prof Nikolaus Haas and Prof Horst Sievert.
The patient had severe diastolic heart failure (HFpEF), NYHA Class III, 6-minute walking test only 10 – 20 meters, LAP 16 mmHg, RAP 7 mmHg.
Occlutech AFR with 10mm fenestration was implanted and hemodynamic changes, pressure balance between left atrium and right atrium seen immediately.
Advantages of Occlutech AFR were very well highlighted by implanting physicians;
Different size options
Retrievable and repositionable
Great alignment on septum thanks to unique Occlutech ball-socket mechanism
No jump of the device/pusher during release
Very straightforward procedure, easy to implant
Immediate relief of high LA pressure and clinical benefits provided as a result
Live Case 2; Occlutech PLD The case was performed by Prof Horst Sievert.
51 y.o male with left heart failure due to large PVL
A huge crescentic mitral leak (19x8,5 mm) in anteromedial location, difficult to reach
Prof Sievert stated that he prefers Occlutech PLD v.s. AVP III, otherwise he will need multiple devices
61PLD18W was implanted via anterograde femoral venous approach with transseptal puncture
Prof. Sievert used Occlutech Delivery Set (ODS) in Occlutech Steerable Sheath (OSS) technique to rotate/orient the device and position it properly close to the valve ring;
14F OSS kept the pusher and the device on the same axis which allowed to retrieve the device and try to align it parallel to the valve ring (second attempt was successful)
OSS provided extra stability and the physicians did not need to create AV loop which decreased the procedure time
OSS really supported to advance the device (comment by Ted Feldman, moderator)
PLD waist perfectly self-centered the defect with the help of gold markers
Anchoring was very nice and pretty effective occlusion was provided immediately (comment by Ted Feldman, moderator)
No interference with the valve leaflets
Quick recovery will be occurred due to the femoral venous approach (comment by Ted Feldman, moderator)
Please feel free to use above arguments and advantages of our devices during your discussions with your customers. We have great features that return on clinical benefits and this had been reassured once more, this time at TCT congress in US.
